An extensive review of the literature found that
heparin (both unfractionated and low- molecular-weight heparins) and heparinoids inhibit the secretion of aldosterone, which can cause hyperkalaemia. This may be additive with the hyperkalaemic effects of angiotensin II
receptor antagonists.